Evaluation of some biomarkers of osteoporosis in women with breast cancer in Al-Najaf Governorate
DOI:
https://doi.org/10.36320/ajb/v15.i3.12684Keywords:
, breast cancer, osteoporosis, parathyroid hormoneAbstract
Introduction: Osteoporosis is a systemic disease that affects the mineral density of bones and their structure, which leads to an increase in the softness of the bones. One in three women after the age of fifty worldwide is affected. Both breast cancer and osteoporosis are common diseases in women. Breast cancer is the most common type of cancer in women, with one in eight women developing breast cancer in their lifetime.Aim of the study Evaluation of some biomarkers of osteoporosis in women with breast cancer represented by cathepsin K, parathyroid hormone, calcium and vitamin D.
methods: The current study was conducted at the National Cancer Center in Al-Najaf province for the period from 8/15/2022 to 1/20/2023. The study included 60 women with breast cancer and 30 healthy women free of diseases, and it was considered a control group. The ages of patients and healthy people ranged between (30-68) years old, vitamin D, calcium, parathyroid hormone, and cathepsin K were evaluated.
Results: For the indicators of vitamin D and parathyroid hormone (PTH), the results of the statistical analysis did not record any significant difference (p>0.05) between the two groups under study. The results of the statistical analysis showed a significant increase (p<0.0001) in the levels of calcium (Ca) and cathepsin K in infected women compared with healthy women. Likelihood (p < 0.005) and calcium with a probability level (p < 0.0001).
Conclusion
Depending on the results reached through the current study, we conclude that there is a high rate of osteoporosis in women with breast cancer. prevalent. Also, an increase in the level of calcium in women with breast cancer, with no difference in parathyroid hormone, which is the most important biomarker for breast cancer diagnosis. An increase in the level of cathepsin K and its negative effect on the level of calcium in women with breast cancer.
Downloads
References
_Chhikara, B. S., & Parang, K. (2023). Global Cancer Statistics 2022: the trends projection analysis. Chemical Biology Letters, 10(1), 451-451.
- Tichy, J. R., Lim, E., & Anders, C. K. (2013). Breast cancer in adolescents and young adults: a review with a focus on biology. Journal of the National Comprehensive Cancer Network, 11(9), 1060-1069. DOI: https://doi.org/10.6004/jnccn.2013.0128
- Cope, W., & Provenzano, E. (2023). The diagnosis and management of lobular carcinoma in situ. Diagnostic Histopathology. DOI: https://doi.org/10.1016/j.mpdhp.2022.12.004
-Thulkar, J., & Singh, S. (2015). Overview of research studies on osteoporosis in menopausal women since the last decade. Journal of mid-life health, 6(3), 10. DOI: https://doi.org/10.4103/0976-7800.165589
- Gallagher, J. C., & Sai, A. (2010). Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. Maturitas, 65(4), 301-307. DOI: https://doi.org/10.1016/j.maturitas.2010.01.002
- Yuan, Y., Chen, X., Zhang, L., Wu, J., Guo, J., Zou, D., ... & Zou, J. (2016). The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis. Progress in Biophysics and Molecular Biology, 122(2), 122-130. DOI: https://doi.org/10.1016/j.pbiomolbio.2015.11.005
- Ramaswamy, B., & Shapiro, C. L. (2003, December). Osteopenia and osteoporosis in women with breast cancer. In Seminars in oncology (Vol. 30, No. 6, pp. 763-775). WB Saunders. DOI: https://doi.org/10.1053/j.seminoncol.2003.08.028
- Bailey, S., & Lin, J. (2021). The association of osteoporosis knowledge and beliefs with preventive behaviors in postmenopausal breast cancer survivors. BMC Women’s Health, 21(1), 1-8. DOI: https://doi.org/10.1186/s12905-021-01430-1
-Cowley, G. P., Smith, J. A., & Gusterson, B. A. (1986). Increased EGF receptors on human squamous carcinoma cell lines. British Journal of Cancer, 53(2), 223-229. DOI: https://doi.org/10.1038/bjc.1986.39
- Khan AA et al. (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. – Osteoporos Int. 28: 1-19. DOI: https://doi.org/10.1007/s00198-016-3716-2
- Sullivan, L. M. (2017). Essentials of biostatistics in public health. Jones & Bartlett Learning.
- Liu, L.; Fan, Y.; Chen, Z.; Zhang, Y.; Yu, J. CaSR Induces Osteoclast Differentiation and Promotes Bone Metastasis in Lung Adenocarcinoma. Front. Oncol. 2020, 10, 305. DOI: https://doi.org/10.3389/fonc.2020.00305
- Rao, Q.; Cheng, L.; Xia, Q.-Y.; Liu, B.; Li, L.; Shi, Q.-L.; Shi, S.-S.; Yu, B.; Zhang, R.-S.; Ma, H.-H.; et al. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): A clinicopathological study emphasizing extrarenal PEComas. Histopatology 2013, 62, 642–650. DOI: https://doi.org/10.1111/his.12059
- Jaber, O.; Kirby, P. Alveolar Soft Part Sarcoma. Arch. Pathol. Lab. Med. 2015, 11, 1459–1462. DOI: https://doi.org/10.5858/arpa.2014-0385-RS
- Olja Mijanovi´c 1,2, Aleksandra Jakovleva 3 , Ana Brankovi´c 4 , Kristina Zdravkova 5 , Milena Pualic 6 , Tatiana A. Belozerskaya 7 , Angelina I. Nikitkina 8 , Alessandro Parodi 9,10 and Andrey A. Zamyatnin, Jr. 9 : Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives, Int. J. Mol. Sci. 2022, 23, 13762.
- Williams JD, Aggarwal A, Swami S, et al. Tumor autonomous effects of vitamin D deficiency promote breast cancer metastasis. Endocrinology 2016; 157(4):1341–1347. DOI: https://doi.org/10.1210/en.2015-2036
- Fleet JC, Burcham GN, Calvert RD, Elzey BD, Ratliff TL. 1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC). Journal of Steroid Biochemistry and Molecular Biology 2020; 198:105557. DOI: https://doi.org/10.1016/j.jsbmb.2019.105557
-Littlewood-Evans, A. J., Bilbe, G., Bowler, W. B., Farley, D., Wlodarski, B., Kokubo, T., ... & Gallagher, J. A. (1997). The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer research, 57(23), 5386-5390.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sarah Mohammed Hussein AL-Thabhawee
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
